[Federal Register Volume 80, Number 241 (Wednesday, December 16, 2015)]
[Notices]
[Page 78170]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31630]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration

[A-570-836]


Glycine From the People's Republic of China: Notice of Amended 
Final Results of Antidumping Duty Administrative Review Pursuant to 
Settlement; 2012-2013

AGENCY: Enforcement and Compliance, International Trade Administration, 
Department of Commerce.
SUMMARY: The Department of Commerce (the Department) is amending the 
final results of the 2012-2013 antidumping administrative review of 
glycine from the People's Republic of China (PRC) with respect to 
Evonik Rexim (Nanning) Pharmaceutical Co., Ltd. and Evonik Rexim S.A.S. 
(collectively, Evonik) pursuant to an agreement that settles the 
related litigation.

DATES: Effective date: December 16, 2015.

FOR FURTHER INFORMATION CONTACT: Edythe Artman or Brian Davis, AD/CVD 
Operations, Office VI, Enforcement and Compliance, International Trade 
Administration, U.S. Department of Commerce, 14th Street and 
Constitution Avenue NW., Washington, DC 20230; telephone: (202) 482-
3931 or (202) 482-7924, respectively.

SUPPLEMENTARY INFORMATION:

Background

    On March 29, 1995, the Department published the antidumping duty 
order on glycine from the PRC.\1\ On October 31, 2014, the Department 
published the final results of its administrative review of the 
Order.\2\ The period of review (POR) is March 1, 2012, through February 
28, 2013. In the Final Results, the Department assigned Evonik, an 
exporter of the subject merchandise from the PRC to the United States, 
the rate assigned to the PRC-wide entity of 453.79 percent for the POR.
---------------------------------------------------------------------------

    \1\ See Glycine from the People's Republic of China: Antidumping 
Duty Order, 60 FR 16116 (March 29, 1995) (Order).
    \2\ See Glycine from the People's Republic of China: Final 
Results of Antidumping Duty Administrative Review; 2012-2013, 79 FR 
64746 (October 31, 2014) (Final Results).
---------------------------------------------------------------------------

    Following the publication of the Final Results, Evonik filed a 
lawsuit with the CIT challenging the Department's final results of 
administrative review. The United States and Evonik have now entered 
into an agreement to settle this dispute. The Court issued its Order of 
Judgment by Stipulation on November 16, 2015.\3\
---------------------------------------------------------------------------

    \3\ See Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. et al v. 
United States, Court No. 14-00296, Order of Judgment by Stipulation 
(November 16, 2015).
---------------------------------------------------------------------------

Assessment of Duties

    Pursuant to the Court's Order of Judgment by Stipulation, the 
Department shall instruct Customs and Border Protection (CBP) to assess 
antidumping duties on all shipments of glycine from the PRC, which were 
entered, or withdrawn from warehouse, for consumption during the period 
March 1, 2012, through February 28, 2013, and that were exported by 
Evonik at a rate of 155.89 percent. The Department intends to issue 
assessment instructions to CBP within 15 days after the date of 
publication of these amended final results of the review in the Federal 
Register.

Cash Deposit Requirements

    As stipulated in the Court's Order of Judgement by Stipulation, the 
order has no effect on entries not made during the POR and does not 
establish a revised cash deposit rate for Evonik.

Notification to Importers

    This notice also serves as a final reminder to importers of their 
responsibility under 19 CFR 351.402(f) to file a certificate regarding 
the reimbursement of antidumping duties prior to liquidation of the 
relevant entries during this review period. Failure to comply with this 
requirement could result in the Secretary's presumption that 
reimbursement of antidumping duties occurred, and the subsequent 
assessment of double antidumping duties.
    We are issuing this determination and publishing these amended 
final results of antidumping duty administrative review pursuant to the 
Court's Order of Judgment by Stipulation.

    Dated: December 9, 2015.
Paul Piquado,
Assistant Secretary for Enforcement and Compliance.
[FR Doc. 2015-31630 Filed 12-15-15; 8:45 am]
BILLING CODE 3510-DS-P